As of 2025-02-13, the Relative Valuation of AtriCure Inc (ATRC) is (26.33) USD. This relative valuation is based on P/E multiples. With the latest stock price at 42.36 USD, the upside of AtriCure Inc based on Relative Valuation is -162.1%.
The range of the Relative Valuation is (24.29) - (28.82) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 28.8x - 42.1x | 34.0x |
Forward P/E multiples | 30.4x - 36.1x | 31.9x |
Fair Price | (24.29) - (28.82) | (26.33) |
Upside | -157.3% - -168.0% | -162.1% |
Date | P/E |
2025-02-12 | -53.06 |
2025-02-11 | -52.00 |
2025-02-10 | -52.63 |
2025-02-07 | -51.36 |
2025-02-06 | -51.31 |
2025-02-05 | -51.77 |
2025-02-04 | -50.92 |
2025-02-03 | -49.73 |
2025-01-31 | -49.94 |
2025-01-30 | -50.86 |
2025-01-29 | -53.11 |
2025-01-28 | -52.73 |
2025-01-27 | -51.16 |
2025-01-24 | -50.83 |
2025-01-23 | -50.57 |
2025-01-22 | -49.48 |
2025-01-21 | -49.64 |
2025-01-17 | -48.19 |
2025-01-16 | -47.15 |
2025-01-15 | -46.31 |
2025-01-14 | -43.45 |
2025-01-13 | -43.08 |
2025-01-10 | -39.34 |
2025-01-08 | -42.16 |
2025-01-07 | -40.96 |
2025-01-06 | -41.95 |
2025-01-03 | -40.12 |
2025-01-02 | -38.08 |
2024-12-31 | -38.28 |
2024-12-30 | -37.89 |
2024-12-27 | -38.39 |
2024-12-26 | -38.52 |
2024-12-24 | -38.20 |
2024-12-23 | -38.22 |
2024-12-20 | -38.48 |
2024-12-19 | -37.64 |
2024-12-18 | -37.89 |
2024-12-17 | -39.46 |
2024-12-16 | -39.51 |
2024-12-13 | -39.67 |
2024-12-12 | -41.07 |
2024-12-11 | -41.72 |
2024-12-10 | -42.56 |
2024-12-09 | -42.51 |
2024-12-06 | -42.90 |
2024-12-05 | -42.73 |
2024-12-04 | -45.48 |
2024-12-03 | -45.24 |
2024-12-02 | -46.42 |
2024-11-29 | -45.29 |